Frontlight ResearchEarly access
Trial site
The University of Kansas Cancer Center, Investigational Drug Services
- 4running trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Head and neck cancer2 trials
- Pancreatic cancer2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Myelodysplastic syndromes1 trial
- Ovarian cancer1 trial
- and 1 more
- Phase
- Phase 13 trials
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Recruiting1 trial
- Lead sponsor
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Pfizer1 trial
Running trials
Active, not recruiting
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Recruiting
Active, not recruiting
Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026